↓ Skip to main content

S100B is required for maintaining an intermediate state with double-positive Sca-1+ progenitor and vascular smooth muscle cells during neointimal formation

Overview of attention for article published in Stem Cell Research & Therapy, September 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
S100B is required for maintaining an intermediate state with double-positive Sca-1+ progenitor and vascular smooth muscle cells during neointimal formation
Published in
Stem Cell Research & Therapy, September 2019
DOI 10.1186/s13287-019-1400-0
Pubmed ID
Authors

Yan Wu, Xin Liu, Ling-Yun Guo, Lei Zhang, Fei Zheng, Shan Li, Xing-Yuan Li, Ye Yuan, Yu Liu, Yu-wen Yan, Shi-You Chen, Jia-Ning Wang, Jin-xuan Zhang, Jun-Ming Tang

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 20%
Student > Ph. D. Student 2 13%
Student > Doctoral Student 1 7%
Professor 1 7%
Student > Master 1 7%
Other 0 0%
Unknown 7 47%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 33%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Business, Management and Accounting 1 7%
Unknown 8 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2019.
All research outputs
#18,697,497
of 23,172,045 outputs
Outputs from Stem Cell Research & Therapy
#1,760
of 2,443 outputs
Outputs of similar age
#257,790
of 344,837 outputs
Outputs of similar age from Stem Cell Research & Therapy
#36
of 50 outputs
Altmetric has tracked 23,172,045 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,443 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,837 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.